高明兴_8399
2021-12-14
好
明年最被看好的美股,辉瑞拟100%溢价收购!
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
1
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":607060139,"tweetId":"607060139","gmtCreate":1639458787519,"gmtModify":1639458787819,"author":{"id":3557375403451824,"authorId":3557375403451824,"authorIdStr":"3557375403451824","name":"高明兴_8399","avatar":"https://static.tigerbbs.com/c106c9c1b7bec94cd1fcd8a7834344f2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":27,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>好</p></body></html>","htmlText":"<html><head></head><body><p>好</p></body></html>","text":"好","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/607060139","repostId":2191332989,"repostType":4,"repost":{"id":"2191332989","pubTimestamp":1639458654,"share":"https://www.laohu8.com/m/news/2191332989?lang=&edition=full","pubTime":"2021-12-14 13:10","market":"us","language":"zh","title":"明年最被看好的美股,辉瑞拟100%溢价收购!","url":"https://stock-news.laohu8.com/highlight/detail?id=2191332989","media":"中国证券报","summary":"分析人士称,阿里纳制药暴涨的原因在于,其可能将被全球制药巨头辉瑞收购。辉瑞当日发布公告称,拟以每股100美元的价格对阿里纳制药展开现金收购。这一价格较阿里纳制药上周五收盘价49.94美元溢价达100%。一夜暴涨逾80%据Wind数据,当地时间12月13日,阿里纳制药开盘涨近90%,随后保持高位运行。值得一提的是,富国银行最新观点称,阿里纳制药为其2022年最看好的美股。","content":"<div>\n<p>文章来源:中国证券报\n一夜之间,股价暴涨超80%,创新药企阿里纳制药成了美股市场的焦点。\n据Wind数据,截至当地时间12月13日收盘,阿里纳制药涨幅达80.38%,股价超过90美元。分析人士称,阿里纳制药暴涨的原因在于,其可能将被全球制药巨头辉瑞收购。\n辉瑞当日发布公告称,拟以每股100美元的价格对阿里纳制药展开现金收购。这一价格较阿里纳制药上周五收盘价49.94美元溢价达100%。\n...</p>\n\n<a href=\"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-14/doc-ikyakumx4059491.shtml\">Web Link</a>\n\n</div>\n","source":"sina_symbol","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>明年最被看好的美股,辉瑞拟100%溢价收购!</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n明年最被看好的美股,辉瑞拟100%溢价收购!\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-14 13:10 北京时间 <a href=https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-14/doc-ikyakumx4059491.shtml><strong>中国证券报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>文章来源:中国证券报\n一夜之间,股价暴涨超80%,创新药企阿里纳制药成了美股市场的焦点。\n据Wind数据,截至当地时间12月13日收盘,阿里纳制药涨幅达80.38%,股价超过90美元。分析人士称,阿里纳制药暴涨的原因在于,其可能将被全球制药巨头辉瑞收购。\n辉瑞当日发布公告称,拟以每股100美元的价格对阿里纳制药展开现金收购。这一价格较阿里纳制药上周五收盘价49.94美元溢价达100%。\n...</p>\n\n<a href=\"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-14/doc-ikyakumx4059491.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","relate_stocks":{"ARNA":"阿里那","BK4534":"瑞士信贷持仓","PFE":"辉瑞","BK4550":"红杉资本持仓","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)"},"source_url":"https://cj.sina.cn/article/normal_detail?url=https://finance.sina.com.cn/stock/usstock/c/2021-12-14/doc-ikyakumx4059491.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191332989","content_text":"文章来源:中国证券报\n一夜之间,股价暴涨超80%,创新药企阿里纳制药成了美股市场的焦点。\n据Wind数据,截至当地时间12月13日收盘,阿里纳制药涨幅达80.38%,股价超过90美元。分析人士称,阿里纳制药暴涨的原因在于,其可能将被全球制药巨头辉瑞收购。\n辉瑞当日发布公告称,拟以每股100美元的价格对阿里纳制药展开现金收购。这一价格较阿里纳制药上周五收盘价49.94美元溢价达100%。\n值得一提的是,日前富国银行发表最新观点称,阿里纳制药是其2022年最看好的美股。\n高溢价收购、被大行唱多,这家创新药企究竟有何来头?\n一夜暴涨逾80%\n据Wind数据,当地时间12月13日,阿里纳制药开盘涨近90%,随后保持高位运行。截至收盘,阿里纳制药涨80.38%,报90.08美元,最新总市值为55.2亿美元。\n分析人士称,阿里纳制药股价暴涨的原因在于,其可能将被全球制药巨头辉瑞收购。\n辉瑞当日发布公告称,将以每股100美元的价格展开现金收购,这一价格较阿里纳制药上周五收盘价49.94美元溢价达100%。这笔交易对阿里纳制药的股权估值为67亿美元,已获得两家公司董事会一致通过,预计在2022年上半年完成。\n值得一提的是,富国银行最新观点称,阿里纳制药为其2022年最看好的美股。这笔交易的初步敲定,“算是圣诞礼物提前到位,眼下这个时间点,不太可能出现(比辉瑞)开价更高的买家”。\n在研免疫炎症药物获看好\n分析人士称,无论是全球制药巨头100%溢价收购,还是海外大行的唱多,其背后都是对阿里纳制药业务的看好。\n辉瑞在公告中表示,阿里纳制药眼下针对胃肠道疾病、皮肤病、心脏疾病研发多款药物,公司旗下治疗溃疡性结肠炎的产品Etrasimod已经进入晚期实验,这款药物对克罗恩病的临床研究也进入中晚期阶段。辉瑞目前的研发管线中也有针对这项疾病的项目,现在刚进入中期试验阶段,按照此前进度将在明年年底完成。仅在美国,受到溃疡性结肠炎影响的人群就达到300万。\n“这项收购补充了辉瑞在炎症和免疫学方面的业务能力,这也是公司的创新引擎。” 辉瑞炎症和免疫学全球总裁兼总经理Mike Gladstone在公告中表示。\n富国银行也表示,阿里纳制药治疗溃疡性结肠炎的创新药Etrasimod实验数据良好,若能获批,有望与来自百时美施贵宝的竞品Zeposia抗衡;若药效好于Zeposia,峰值销售额将达到25亿美元。","news_type":1},"isVote":1,"tweetType":1,"viewCount":663,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/607060139"}
精彩评论